1.
J Clin Psychopharmacol
; 38(3): 263-265, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29613864
Assuntos
Monitoramento de Medicamentos , Inflamação/sangue , Risperidona/sangue , Risperidona/uso terapêutico , Esquizofrenia/sangue , Esquizofrenia/tratamento farmacológico , Antipsicóticos/sangue , Antipsicóticos/uso terapêutico , Humanos , Inflamação/complicações , Masculino , Pessoa de Meia-Idade , Esquizofrenia/complicações
2.
Tidsskr Nor Laegeforen
; 125(1): 27-8, 2005 Jan 06.
Artigo
em Norueguês
| MEDLINE
| ID: mdl-15643459
RESUMO
BACKGROUND: Levels of cyclic guanosine 3',5'-monophosphate (cGMP) are elevated in plasma and urine from patients with some cardiovascular diseases and some types of cancer. MATERIALS AND METHODS: This paper is based on studies of cGMP as a biomarker. RESULTS AND INTERPRETATION: It is well documented that cGMP levels are elevated in plasma in patients with heart failure and various leukaemias and in urine from patients with gynaecological cancers. Because of great interindividual variation in levels, cGMP is less suitable in primary diagnostics, but appears to be a sensitive marker in individual follow up in some diseases.